Tumour marker for melanoma found

by Medindia Content Team on  December 14, 2002 at 3:14 PM General Health News
RSS Email Print This Page Comment
Font : A-A+

Tumour marker for melanoma found
According to a recent study it is observed that a molecular marker is linked to prognosis in malignant melanoma. In cancer research today, there is increasing emphasis on looking for molecules specific to that cancer which might aid in monitoring the progression of the disease. Scientists at New York University now report on a molecular marker called HDM2 which appears to be important in tracking melanoma, the most serious form of skin cancer.

They studied a group of 132 patients with various grades of melanoma for many years. Those with high levels of HDM2 had a good prognosis, while those with low levels had a poorer outcome. Levels were not correlated, however, with tumour thickness which is traditionally used for prognosis.

It's known that HDM2 is involved in one of the pathways of the tumour suppressor gene called p53, which plays a role in many other cancers. However, it is not clear why high levels are linked to a good outcome in melanoma. But its role as a molecular marker may well help doctors to target and refine therapies to the individual patient with melanoma, the researchers say.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Skin Cancer Ultra-Violet Radiation Cysts and Tumours Tumor Markers For Cancer Diagnosis and Prognosis Melanoma 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive